Systematised control over medicines and other related products with a low narcotics content.

15.08.2011

Legal Update No. 262. 

Goltsblat BLP advises that resolution of the Government of the Russian Federation No. 599 “On control measures in relation to medicaments containing a small quantity of narcotic substances, psychotropic substances or their precursors included on the list of narcotic substances, psychotropic substances and their precursors subject to control in the Russian Federation” was passed on 20 July and came into effect on 27 July 2011.

The resolution covers control over medicaments containing a small quantity of narcotic substances, psychotropic substances or their precursors included on lists  II, III and IV of such medicaments and substances subject to control in Russia.

The resolution makes the given products subject to the usual control measures applicable to the narcotic and psychotropic substances they contain.

This does not, however, apply to medicaments containing other pharmacologically active substances alongside a small dose of narcotic or psychotropic ones. Such medicaments are subject to the following control measures:

  • a ban on dispatch by post, including internationally, or in the guise of humanitarian aid (apart from in emergencies when the given medicaments are forwarded to constituent entities of the Russian Federation by decision of the Government of the Russian Federation);
  • delivery to individuals of the given medicaments intended for medicinal use in the manner established by the Ministry for Health and Social Development of Russia on agreement with the Federal  Drug Control Service of Russia;
  • delivery to individuals of medicaments containing small doses of codeine or its salts under a doctor’s (paramedic’s) prescription (this provision comes into effect on 1 June 2012).

It is notable that the restrictions set for medicaments containing a small dose of codeine or its salts apply to a quite broad range of medicines in high demand among the population: pentalgine, solfadeine, caffetine, sedalgine, nurofen, codelac, cofex, terpincode and others.

In addition, the legal act under review excludes from resolution of the Government of the Russian Federation of 4 November 2006 No. 648 provisions relating to licensing of production, manufacture, processing, storage, transportation, delivery, sale, distribution, acquisition, use and destruction by legal entities of medicaments containing small doses of narcotics and psychotropic substances (List II and List III).

For additional information, please contact:

Nina Belozertseva,
Head of Group, Healthcare and Pharmaceuticals
Goltsblat BLP,
T: +7 (495) 287 44 44,
E: info@gblplaw.com

Contact details

For all issues related to publications, news and press releases, please contact:

Ksenia Soboleva

Head of PR and Communications

Subscription

If you would like to receive our legal alerts and updates highlighting current legal issues relevant to your areas of interest and providing expert commentary by our lawyers, please click on "Sign Up" and fill out the form.